Retinal dysfunction of contrast processing in major depression also apparent in cortical activity

European Archives of Psychiatry and Clinical Neuroscience

Volumn 265, Issue 4, 2015, Pages 343-350

  Bubl, Emanuel ^a   Kern, Elena ^a   Ebert, Dieter ^a   Riedel, Andreas ^a   Tebartz van Elst, Ludger ^a,c   Bach, Michael ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c University Medical School of Freiburg   (Germany)

Author keywords

Contrast sensitivity; Dopamine; Major depression; Visual evoked potentials

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MIRTAZAPINE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AMPLITUDE MODULATION; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LATERAL GENICULATE BODY; MAJOR DEPRESSION; MALE; MONOTHERAPY; OCCIPITAL CORTEX; PATTERN ELECTRORETINOGRAM; PRIORITY JOURNAL; PSYCHOMETRY; RETINA DISEASE; TREATMENT DURATION; VISUAL CORTEX; VISUAL STIMULATION; BRAIN CORTEX; COMPLICATION; CONTRAST SENSITIVITY; ELECTROENCEPHALOGRAPHY; ELECTRORETINOGRAPHY; FOURIER ANALYSIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; RETINAL DISEASES; STATISTICS;

ADULT; CEREBRAL CORTEX; CONTRAST SENSITIVITY; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; FOURIER ANALYSIS; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; PSYCHIATRIC STATUS RATING SCALES; RETINAL DISEASES; STATISTICS AS TOPIC;

EID: 84939418358     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-014-0573-x     Document Type: Article

References (62)

1. WHO (2004) WHO | The global burden of disease: 2004 update. In: WHO. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/. Accessed 13 Nov 2013
2. Lopez AD, Murray CCJL (1998) The global burden of disease, 1990–2020. Nat Med 4:1241–1243. doi:10.1038/3218
3. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161–1169. doi:10.1038/nn.2647
4. American Psychiatric Association (2000) Diagnostic statistical manual of mental disorders: DSM-IV-TR, Revised. American Psychiatric Association, Washington, DC
5. Randrup A, Bræstrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309–314. doi:10.1007/BF00492370
6. Chaudhury D, Walsh JJ, Friedman AK et al (2013) Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493:532–536. doi:10.1038/nature11713
7. Kessler RC, Chiu WT, Demler O, Walters EE (2005) Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 62:617–627. doi:10.1001/archpsyc.62.6.617
8. Tye KM, Mirzabekov JJ, Warden MR et al (2013) Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493:537–541. doi:10.1038/nature11740
9. Ebert D, Ebmeier KP (1996) The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry. Biol Psychiatry 39:1044–1050. doi:10.1016/0006-3223(95)00320-7
10. Ebert D, Berger M (1998) Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology 140:1–10
11. Lammers CH, Diaz J, Schwartz JC, Sokoloff P (2000) Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 5:378–388
12. Klimek V, Schenck JE, Han H et al (2002) Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry 52:740–748. doi:10.1016/S0006-3223(02)01383-5
13. Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151–1159. doi:10.1016/j.biopsych.2005.09.018
14. Krishnan V, Han M-H, Graham DL et al (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391–404. doi:10.1016/j.cell.2007.09.018
15. Krishnan V, Nestler EJ (2010) Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167:1305–1320. doi:10.1176/appi.ajp.2009.10030434
16. Wilson RS, Nag S, Boyle PA et al (2013) Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2013.2224
17. Bubl E, Tebartz van Elst L, Gondan M et al (2009) Vision in depressive disorder. World J Biol Psychiatry 10:377–384
18. Bubl E, Kern E, Ebert D et al (2010) Seeing gray when feeling blue? Depression can be measured in the eye of the diseased. Biol Psychiatry 68:205–208
19. Bubl E, Ebert D, Kern E et al (2012) Effect of antidepressive therapy on retinal contrast processing in depressive disorder. Br J Psychiatry 201:151–158. doi:10.1192/bjp.bp.111.100560
20. Teranishi T, Negishi K, Kato S (1983) Dopamine modulates S-potential amplitude and dye-coupling between external horizontal cells in carp retina. Nature 301:243–246
21. Ghilardi MF, Marx MS, Bodis-Wollner I et al (1989) The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 25:357–364. doi:10.1002/ana.410250407
22. Pereda A, Triller A, Korn H, Faber DS (1992) Dopamine enhances both electrotonic coupling and chemical excitatory postsynaptic potentials at mixed synapses. PNAS 89:12088–12092
23. Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vision Res 34:2629–2638
24. Tebartz van Elst L, Greenlee MW, Foley JM, Lucking CH (1997) Contrast detection, discrimination and adaptation in patients with Parkinson’s disease and multiple system atrophy. Brain 120(Pt 12):2219–2228
25. Langheinrich T, Tebartz van Elst L, Lagreze WA et al (2000) Visual contrast response functions in Parkinson’s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 111:66–74
26. Bach M (2007) The Freiburg visual acuity test-variability unchanged by post hoc re-analysis. Graefes Arch Clin Exp Ophthalmol 245:965–971
27. Bach M (2000) Freiburg evoked potentials. http://www.michaelbach.de/ep2000.html
28. American Clinical Neurophysiology Society (2006) Guideline 5: guidelines for standard electrode position nomenclature. J Clin Neurophysiol 23:107–110
29. Bach M, Meigen T, Strasburger H (1997) Raster-scan cathode-ray tubes for vision research-limits of resolution in space, time and intensity, and some solutions. Spat Vis 10:403–414
30. Meigen T, Bach M (1999) On the statistical significance of electrophysiological steady-state responses. Doc Ophthalmol 98:207–232
31. Bach M, Meigen T (1999) Do’s and don’ts in Fourier analysis of steady-state potentials. Doc Ophthalmol 99:69–82
32. WaveMetrics (2014) WaveMetrics—scientific graphing, data analysis, curve fitting and image processing software. http://www.wavemetrics.com/index.html. Accessed 11 Nov 2014
33. R Development Core Team (2014) R: A language and environment for statistical computing. http://www.R-project.org. Accessed 18 Aug 2014
34. Ben-Shlomo G, Bach M, Ofri R (2007) Temporal and spatial frequencies interact in the contrast transfer function of the pattern electroretinogram. Vision Res 47:1992–1999. doi:10.1016/j.visres.2007.04.009
35. Normann C, Schmitz D, Fürmaier A et al (2007) Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry 62:373–380. doi:10.1016/j.biopsych.2006.10.006
36. Joost W, Bach M, Schulte-Mönting J (1992) Influence of mood on visually evoked potentials: a prospective longitudinal study. Int J Psychophysiol 12:147–153
37. Ohzawa I, Sclar G, Freeman RD (1982) Contrast gain control in the cat visual cortex. Nature 298:266–268. doi:10.1038/298266a0
38. Heinrich TS, Bach M (2001) Contrast adaptation in human retina and cortex. IOVS 42:2721–2727
39. Heinrich TS, Bach M (2002) Contrast adaptation in retinal and cortical evoked potentials: no adaptation to low spatial frequencies. Vis Neurosci 19:645–650. doi:10.1017/S0952523802195095
40. Solomon SG, Lennie P (2005) Chromatic gain controls in visual cortical neurons. J Neurosci 25:4779–4792. doi:10.1523/JNEUROSCI.5316-04.2005
41. Hadjiconstantinou M, Neff NH (1984) Catecholamine systems of retina: a model for studying synaptic mechanisms. Life Sci 35:1135–1147. doi:10.1016/0024-3205(84)90184-X
42. Vasile RG, Duffy FH, McAnulty G et al (1989) Abnormal visual evoked response in melancholia. Biol Psychiatry 25:785–788. doi:10.1016/0006-3223(89)90250-3
43. Vasile RG, Duffy FH, McAnulty G et al (1992) Abnormal flash visual evoked response in melancholia: a replication study. Biol Psychiatry 31:325–336. doi:10.1016/0006-3223(92)90226-P
44. Henry GM, Buchsbaum M, Murphy DL (1976) Intravenous l-DOPA plus carbidopa in depressed patients: average evoked response, learning, and behavioral changes. Psychosom Med 38:95–105
45. Buchsbaum MS, Kammen DPV, Murphy DL (1977) Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients. Psychopharmacology 51:129–135. doi:10.1007/BF00431728
46. Zhao Y, Kerscher N, Eysel U, Funke K (2001) Changes of contrast gain in cat dorsal lateral geniculate nucleus by dopamine receptor agonists. NeuroReport 12:2939–2945
47. Bartel P, Blom M, van der Meyden C, de Sommers K (1988) Effects of single doses of diazepam, chlorpromazine, imipramine and trihexyphenidyl on visual-evoked potentials. Neuropsychobiology 20:212–217. doi:10.1159/000118502
48. Bulens C, Meerwaldt JD, van der Wildt GJ, Keemink CJ (1989) Visual contrast sensitivity in drug-induced Parkinsonism. J Neurol Neurosurg Psychiatry 52:341–345
49. Parkinson D (1989) Evidence for a dopaminergic innervation of cat primary visual cortex. Neuroscience 30:171–179
50. De Keyser J, Ebinger G, Vauquelin G (1989) Evidence for a widespread dopaminergic innervation of the human cerebral neocortex. Neurosci Lett 104:281–285. doi:10.1016/0304-3940(89)90589-2
51. Müller CP, Huston JP (2007) Dopamine activity in the occipital and temporal cortices of rats: dissociating effects of sensory but not pharmacological stimulation. Synapse 61:254–258. doi:10.1002/syn.20366
52. Volkow ND, Tomasi D, Wang G-J et al (2009) Hyperstimulation of striatal D2 receptors with sleep deprivation: implications for cognitive impairment. Neuroimage 45:1232–1240. doi:10.1016/j.neuroimage.2009.01.003
53. Volkow ND, Tomasi D, Wang G-J et al (2012) Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J Neurosci 32:6711–6717. doi:10.1523/JNEUROSCI.0045-12.2012
54. Buchsbaum MS, Gerner R, Post RM (1981) The effects of sleep deprivation on average evoked responses in depressed patients and in normals. Biol Psychiatry 16:351–363
55. Vijayraghavan S, Wang M, Birnbaum SG et al (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376–384. doi:10.1038/nn1846
56. Volkow ND, Wang GJ, Fowler JS et al (1997) Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154:50–55
57. Cools R, D’Esposito M (2011) Inverted-u-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69:e113–e125. doi:10.1016/j.biopsych.2011.03.028
58. Landau AM, Chakravarty MM, Clark CM et al (2011) Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates. Neuropsychopharmacology 36:511–518. doi:10.1038/npp.2010.182
59. Baldinger P, Lotan A, Frey R et al (2014) Neurotransmitters and electroconvulsive therapy. J ECT 30:116–121. doi:10.1097/YCT.0000000000000138
60. Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14:609–625. doi:10.1038/nrn3381
61. Seifritz E, Müller MJ, Annen O et al (1997) Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. J Psychiatr Res 31:543–554
62. Goldapple K, Segal Z, Garson C et al (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61:34–41. doi:10.1001/archpsyc.61.1.34